1. France Stocks

  2. •

    Technology services

  3. •

    Packaged software
Equasens SA

Equasens SA

29.10
EUR
+0.15
(+0.52%)
927.43MMarket Cap
Mar 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
7.48
7.65
7.58
8.57
8.67
9.92
10.55
11.4
12.85
14.24
14.64
- -
15.73
- -
Basic EPS, GAAP
1.04
1.14
1.25
1.37
1.55
1.7
1.89
2.04
2.6
3.09
3.13
- -
2.62
- -
Free Cash Flow per Basic Share
0.56
0.89
1.02
1.11
1.3
1.18
1.57
1.83
2.47
3.11
2.87
3.13
3.14
- -
Dividend per Share
0.42
0.51
0.58
0.6
0.65
0.75
0.85
0.9
0.95
1.05
1.15
- -
1.25
- -
Book Value per Share
4.99
5.43
6.05
6.81
6.86
7.61
8.49
9.51
10.59
12.63
14.59
- -
16.78
14.59
Tangible Book Value per Share
2.46
2.83
3.38
3.82
2.99
2.92
3.19
2.73
2.39
4.54
5.92
- -
5
5.92
Basic Weighted Avg Shares
15
15
15
15
15
15
15
15
15
15
15
15
15
15
Sales/Revenue/Turnover
113
115
113
128
130
148
159
172
193
214
220
- -
237
- -
Operating Margin (%)
20.38
22.27
24.93
24.45
26.46
26.19
25.76
27.16
26.04
26.27
25.37
- -
20.24
- -
Depreciation Expense
3
2
3
4
5
5
8
9
12
14
14
16
19
- -
Net Income, GAAP
16
17
19
21
23
25
28
31
39
46
47
- -
39
- -
Effective Tax Rate (%)
35.2
35.45
35.05
33.66
30.46
31.87
31.43
29.16
20.48
11.36
16.9
- -
20.56
- -
Profit Margin (%)
13.95
14.85
16.56
16.02
17.89
17.13
17.91
17.88
20.26
21.66
21.41
- -
16.63
- -
Working Capital
35
40
50
45
38
42
25
30
28
39
24
- -
51
24
LT Debt
1
1
1
3
14
37
47
55
59
48
47
37
41
47
Total Equity
76
82
92
104
105
117
132
149
165
197
228
- -
263
228
Return on Invested Capital (%)
19.84
20.17
20.67
19.89
20.05
18.74
16.01
15.92
17.09
19.16
16.43
- -
- -
- -
Return on Capital (%)
21.39
21.21
21.18
19.06
18.87
17.04
15.32
14.22
16.12
17.56
16.43
- -
- -
- -
Return on Common Equity (%)
22.27
21.67
21.85
21.36
22.69
23.51
23.53
22.68
25.88
26.59
23
- -
- -
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'22
Jun'23
Dec'23
ST Debt
18
20
19
LT Borrowings
41
41
39
LT Finance Leases
7
7
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
15
15
Market Capitalization
1,127
1,269
927

Working Capital

EUR

•

in mil. unless spec.
Dec'22
Jun'23
Dec'23
Total Current Assets
137
139
132
Cash, Cash Equivalents & STI
68
74
55
Accounts Receivable, Net
47
44
53
Inventories
9
8
10
Total Current Liabilities
98
119
108
Payables & Accruals
- -
- -
- -
ST Debt
18
20
19
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
12.93%
12.5%
-0.79%
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
220
2024
- -
- -
- -
2025
- -
- -
237

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
3.13
2024
- -
- -
- -
2025
- -
- -
2.62

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.15
2024
- -
- -
- -
2025
- -
- -
1.25

Company Description

Company Profile APIChatGPT
CEO
Denis Serge Claude Supplisson
Full Time Employees
1,462
Sector
Technology services
Industry
Packaged software
Address
5 AllEe de Saint Cloud Villers-lès-Nancy GE France 54600
IPO Date
Oct 20, 2000
Website
equasens.com
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
Equasens Société anonyme (Euronext: EQS.PA) develops and provides healthcare IT solutions across Europe, including software suites for pharmacy management, electronic patient records, digital health robotics, and electronic equipment; dispensing robots; patient data exchange platforms; order and inventory management tools; telemedicine and hospital-at-home services; and financing solutions for leased healthcare equipment. Its core offerings encompass the id. suite for pharmacies (including id. PATIENT for data exchange, id. VENTE for secure prescription sales, id. COMMANDE for orders, Ségur id. services, FARMACLICK protocol, DIFARM for wholesalers, and PHARE for retail); solutions for medical practices and nursing homes such as MediStory, id. DESK dashboards, id. UP! apps, Miaterapia patient apps, and ExpressVitale modules; emergency management software like ResUrgences; and electronic devices including KAP&LINK2 terminals, eS-KAP-Ad mobile devices, and NOVIAcare sensors. The company operates through divisions including Pharmagest for pharmacy technologies, Medical Solutions for practice management, Axigate Link for medico-social and hospital software, e-Connect for smart devices, and Fintech for equipment leasing, serving pharmacies, hospitals, nursing homes, private practitioners, regional health communities, and wholesalers in France and other European markets. Founded in 1996 and headquartered in Villers-lès-Nancy, France, Equasens (formerly Pharmagest Interactive SA) is a subsidiary of Marque Verte Santé and leads in digital solutions for city-hospital-medico-social coordination, with over 1,400 employees supporting interoperability, data security, and patient care optimization. In recent developments, Equasens completed the acquisition of the DIS (GESDIS, FACDIS, ARCADIS) and ResUrgences businesses from Novaprove in July 2025, adding over 300 public healthcare clients and €5 million in revenue to bolster its Axigate Link division's hospital and medico-social offerings like HOSPILINK and TITANLINK; acquired a 90% stake in Calimed SAS in December 2024, integrating its cloud-based easy-care and Calimed Santé SaaS platforms for physicians and surgeons to expand the Medical Solutions division; and launched AI-driven tools like the Loquii voice consultation assistant while pursuing 10% revenue growth into 2025.